Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Sectors

Warburtons chomps on Artful Baker

Break maker's Batch Ventures will announce our second investment later this month.


Feb 14, 2021

Kraken Ventures awakes for crypto

Brandon Gath, previously head of corporate development at Kraken, has been made general partner of Kraken Ventures.

Feb 14, 2021

SR One expands venture team

Chris Chai and Peter Van Vlasselaer, both former executives at SR One portfolio companies, have been hired by the GSK-backed VC firm as venture partners.

Feb 12, 2021

Corporate venturing deal net: 8-12 February 2021

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Feb 12, 2021

Alphabet helps provide $15m for Nothing

The stealthy consumer device startup took its total funding to $22m in just four months, with Alphabet unit GV leading its series A round.

Feb 12, 2021

Rover fetches SPAC for reverse merger

The Petco-backed pet services provider is set to be valued at about $1.6bn in a deal that will involve it listing on the Nasdaq Capital Market.

Feb 12, 2021

Nationwide expands venture capital allocation to $350m

The financial services and insurance group had initially earmarked about $100m for strategic investments in 2017 and has since backed 25 companies.

Feb 12, 2021

Hyperfine finds $90m in series D round

Alphabet's GV unit and Huami both took part as the portable MRI device developer completed an oversubscribed series D round.

Feb 12, 2021

GrubMarket gets $90m in series D

Marubeni Ventures helped the online fresh food supplier push its overall funding past the $240m mark as it looks to expand further across the United States.

Feb 12, 2021

Funds and incubators: February 8-12, 2021

A round up of the week's new fund and incbuator launches.

Feb 12, 2021

Binhui Biotech brings in series C funding

The Lepu-backed genetic cancer therapy developer has completed a $94.9m round co-led by CICC Capital, Share Capital, Vertex Ventures China and Qianhai FOF.

Feb 12, 2021

Pipeline Therapeutics sucks up $80m

Cleva Pharma Capital backed a series C round that will support the clinical progress of drug candidates for sensorineural hearing loss and multiple sclerosis.

Feb 12, 2021
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here